Researchers at Binghamton University (USA) have announced a breakthrough approach in developing cancer treatment vaccines. By combining mRNA technology with the biological characteristics of the SARS-CoV-2 virus, this method offers hope for a high-precision treatment system that utilizes the body’s existing defense capabilities.
the mechanism of “tagging” tumors with spike proteins Unlike traditional methods, this mRNA vaccine does not attack the tumor directly but acts as an “instructor” for the immune system.
- Expression Process: The vaccine delivers genetic instructions into cancer cells, causing them to produce the spike protein—the signature protein of the virus that causes COVID-19—on the tumor’s surface.
- Activation of Attack: Since most of the global population already possesses immune memory of the spike protein (through prior vaccination or infection), the immune system immediately recognizes the “tagged” tumor cells as foreign invaders and launches a targeted strike to destroy them.
delivery via smart nanoparticles To deliver the mRNA to the correct destination, scientists utilize specially engineered nanoparticle systems. This technology helps overcome biological barriers often encountered by traditional chemotherapy, ensuring that the mRNA penetrates deep into the tumor before releasing its genetic instructions.
prospects and research roadmap Currently, this method has yielded promising results in laboratory settings. While extensive clinical trials are required before widespread application, experts believe this could be the key to addressing not only cancer but also infectious diseases and immunomodulation in the future. Leveraging the “echoes” of pandemic immunity is considered a clever strategy to shorten the body’s response time against malignant cells.
Source: https://nld.com.vn/my-phat-trien-vac-xin-ung-thu-mrna-dua-tren-du-am-covid-19-19625121816444337.htm